Gelteq Limited Ordinary Shares
Here’s whether Gelteq Limited Ordinary Shares (GELS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+23.8%); rising volume confirms the move (2.93x 30d avg). Concerns: 50-day MA is falling (-2.54% over 10 days); weak 1-year return of -57.0%. Currently 62.4% off its 52-week high. Score: +3/7.
GELS is in a confirmed uptrend, trading above both its 50-day ($0.59) and 200-day ($0.92) moving averages. An RSI of 66.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -57.0% compares to +22.9% for SPY (trailed the market by 79.8%). The current 62.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.